Star And Portfolio Firm Electra Roll Out With Focus On Rare Immunologic Disease

 
• By Joseph Haas

Star will employ a hub-and-spoke model to launch portfolio companies focused on specific biological areas. The first company, Electra, will emphasize unmet medical needs and therapies that can address multiple diseases.

Star Feature Image
Star and its portfolio companies will seek novel therapies for multiple indications • Source: Alamy

More from Financing

More from Business